Gesponsert
Profit margins, US medicine supplies may get hit: Biocon
Posted
Biocon anticipates potential challenges from proposed US tariffs on pharmaceutical imports, which could squeeze profit margins and affect the affordability of generic medicines. With the US being its largest market, Biocon is strategizing to navigate the impact, considering factors like tariff rates and competitor responses. The company is also focusing on expanding its presence in Europe to mitigate risks.
Search
Nach Verein filtern
- National
- International
- Business
- Technology
- Health
- Ausbildung
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
UAE: Dubai-based athlete embarks on extreme 10,000km triathlon in 100 days for cancer ahead of T100 finale
Dubai endurance athlete Ghani Souleymane is undertaking a groundbreaking 100-day triathlon...
India–Oman trade pact talks near completion, announcement expected soon; petroleum and urea dominate imports
India and Oman are poised to finalize and sign their free trade agreement (FTA), potentially...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Deutsch
